Galapagos N.V. (GLPG)
NASDAQ·Healthcare·Biotechnology
$28.48
+0.04%
Mkt Cap $2.18B
Analyst Ratings
No recent rating data.
Price Target (6 analysts)
$36.50
Range $33.00 – $40.00
Implied Upside
+28.2%
Consensus $36.50 vs current $28.48
NASDAQ·Healthcare·Biotechnology
$28.48
+0.04%
Mkt Cap $2.18B
No recent rating data.
Price Target (6 analysts)
$36.50
Range $33.00 – $40.00
+28.2%
Consensus $36.50 vs current $28.48